Mr. Brian Pedlar reports

COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER FISCAL 2023 FINANCIAL RESULTS

Covalon Technologies Ltd. will release its Q3 fiscal 2023 financial results on Wednesday, Aug. 16, 2023, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, Aug. 16, 2023, at 9 a.m. ET.

To view, listen to and participate in the webcast, please access the live webcast on-line.

To listen and participate via the conference call, please dial the following numbers.

North American toll-free:  1-888-259-6580

Local (Toronto):  416-764-8624

Conference ID:  27101802

Participants will be able to ask questions of company management during the question-and-answer portion of the conference call, either by asking them on the call or by submitting them using the chat function on the webcast.

A recording of the call will be available on the company's website under news and events on the investors tab.

Copies of Covalon's financial statements and MD&A (management's discussion and analysis) can be obtained on SEDAR+ and under SEDAR+ filings on the investors tab of Covalon's website.

About Covalon Technologies Ltd.

Covalon Technologies is a patient-driven medical device company, built on the relentless pursuit to help the most vulnerable patients have a better chance at healing. Through a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention and medical device coatings, the company offers innovative, gentler and more compassionate options for patients to heal with less infections, less pain and better outcomes. Its solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon's name; and (ii) by developing and commercializing medical products for other medical companies under development and licence contracts.

We seek Safe Harbor.